OS Therapies Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Operating income | -$28.7M | -$6.8M | -$4.3M |
| Cash from operations | -$14.2M | -$7.3M | -$3.0M |
| Capital expenditure | $466,423 | — | — |
| Free cash flow | -$14.7M | — | — |
| Total assets | $6.8M | $5.5M | $798,082 |
| Total liabilities | $11.9M | $4.7M | $24.8M |
Shares outstanding 44.5M · Free float 92.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.